The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, the adoption of these tools by healthcare professionals is comparatively low. Senior User Experience Consultant Stewart Anderson explains why.
In the digital age, the technology exists to better capture, analyze and share healthcare data to drive better patient outcomes, to improve their quality of life and ultimately to analyze aggregated, anonymized data to enhance our understanding of the disease and population-level outcomes. Continue reading “Why aren’t doctors using digital therapeutics?”
Imagine a world where medical records are never lost, doctors and hospitals are more efficient, and no matter where you are, your physician can access your notes at the click of a button. That’s the attractive promise of the electronic medical record (EMR).
Hospitals across the western world are buying into EMR systems. The prestigious Great Ormond Street Hospital in London has just embarked on a £50 million project to digitalise its paper records. Walk through the hospital corridors and you will spot banners with slogans such as ‘Future Proof’ and ‘We can do this,’ designed to assure doctors of the benefits of the new technology. Continue reading “Rethinking electronic medical records”
Customers have an abundance of choice and businesses need to find a way to differentiate themselves from the crowd. Customer experience is quickly becoming those defining criteria.
While price and quality play a significant role in purchasing decisions, it is by no means the only consideration.
65% of UK buyers say that customer experience helps them decide between buying options.
54% of U.S. consumers say customer experience at most companies needs improvement.
Increasingly, customers are looking for highly-personalized service and products that are delivered in the exact form, and at the exact moment, they require it. Businesses that can anticipate these needs are often the ones that rise to the top. Most often, it is not the cheapest, but the most responsive companies, that win.
But what matters most to customers when it comes to customer experience? And how can you use technology to meet their expectations?
A proactive approach for effective clinical supply management is essential for reducing the risk of supply-related delays, stock-outs, and excess inventory. Utilizing simulations to performing “What If” scenario planning for demand forecasting is a powerful, insightful supply chain management tool, particularly for complex studies with multiple variables. However, forecasts are only as good as the models upon which they are built and the inputs provided.
This article explores how to drive excellence within the forecasting process and how to utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines and to identify potential supply-related issues before they negatively impact your study.
Key takeaways include:
The importance of pre-study forecasting for initial demand planning and smoother site start-up
Critical data points that should be included in every forecast
How to plan for and manage mid-study changes and determine when reforecasting may be appropriate
As companies face pressure to bring drugs to market quicker & at minimal cost, pharma & biotech companies are outsourcing parts of the drug development & manufacturing process. Outsourcing eliminates the need to maintain expensive in-house facilities & provides access to other technologies & expertise.
Getting the attention of busy physicians and hospital executives is more challenging than ever for medical device manufacturers across the globe. Doctors are busier and have less time to see patients, let alone talk to a sales representative. Successful medical device marketers have learned how to harness the power of digital to achieve their key objectives.
Read on this article and discover solutions to the most common challenges faced by medical device companies. You’ll learn how to:
Reach HCPs by meeting them on their terms
Scale education programs with digital events
Maintain strong distributor relationships through personalized content experiences
Understand HCP demographics by creating robust data profiles
As the U.S. shifts to value-based care models, getting reimbursement claims accurate from the get-go becomes ever more important. Driving Payment Accuracy is of critical importance to many health plans. It’s important to understand how the market is evolving, how to take advantage of best practices, and how to avoid common pitfalls associated with some approaches.
This article provides an in-depth review of the top techniques making a positive impact in the market, and explains why other methodologies are proving less effective.
Based on responses from over 100 marketers worldwide, working at companies with at least 1,000 employees in various industries, the report overwhelmingly found that despite a desire by marketers to confront the obstacles of digital customer engagement, they still struggle with the basics.
Key findings include:
One-third of companies report poor data analytics as an issue
84% of companies say the main purpose of their website is merely to act as a company brochure
19% of respondents say websites are still not GDPR compliant
71% of companies invest in paid social media for brand awareness as opposed to only 36% investing in SEO
80% of respondents say content maintenance takes up the most time for web teams
64% say well-targeted content is their biggest web optimization challenge
After news broke about a health data partnership between Google and Ascension Health, sparking a federal investigation, the tech giant and health system released statements defending the project. Source: Google Cloud > Our partnership with Ascension
UnitedHealth Group has named Andrew Witty, CEO of Optum, as its new president, will oversee enterprise business strategy formulation, enterprise business development and partnerships and oversight of enterprise research and development and clinical capacities in addition to his responsibilities as Optum chief executive officer. Source: UnitedHealth Group > Sir Andrew Witty Named UnitedHealth Group President
Arkuda bags $44M to target progranulin and head off inherited dementia. Armed with $44 million from the likes of Atlas Venture and Pfizer Ventures, Arkuda Therapeutics is going after progranulin, a protein that plays a role in neuronal health and lysosomal function, to treat an inherited form of dementia. The company aims to push its lead program into the clinic in 2021. Source: Global Genes > Arkuda Therapeutics Raises $44 Million to Treat Rare Form of Dementia
ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer studies. Three years after tech billionaire Sean Parker’s Institute for Cancer Immunotherapy became the first research institution to launch a human trial of CRISPR-edited cells in cancer, the scientists running that trial are reporting that the therapy has been well tolerated by three patients. Source: EurekAlert > First-In-US trial of CRISPR-edited immune cells for cancer appears safe
Biogen and Samsung expand biosimilar deals to cover Lucentis, Eylea, and China. After a successful partnership with its biosimilar joint venture Samsung Bioepis, Biogen has decided to move into more drugs and markets. In an expanded deal, Biogen is putting down $100 million upfront for copycats to Novartis and Roche’s Lucentis, Regeneron and Bayer’s Eylea, and new rights for anti-TNF drugs in China. Source: Xconomy > Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis
Don’t wait up. FTC delays Novartis’ Sandoz deal with Aurobindo into 2020: report. Novartis’ $1 billion asset hive-off to Aurobindo Pharma likely won’t happen this year, and once again it’s antitrust worries holding up the transaction. Amid some unusual scrutiny for pharma’s 2019 deal-making, the U.S. Federal Trade Commission is reportedly looking closer at a lawsuit Aurobindo faces. Source: ETMarkets News > Aurobindo’s buyout of Sandoz assets delayed on FTC query
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters. In an offer aimed at settling the thousands of opioid lawsuits it faces, Teva has proposed an eye-popping $23 billion-plus deal with plaintiffs. So far, that offer hasn’t gained much traction, though, leaving the drugmaker with a legal overhang that now tops 10 figures. Source: The New York Times > Teva Pharm Says Opioid Settlement Will Not Derail Ability to Cut Debt
Based on a Fireside Chat webcast on migration theory, practice and technology featuring Nick Cavalancia, Techvangelism, and Chris Clark, CEO Trusted Data Solutions.
If you need to migrate your email archive from on-premises to the cloud, wouldn’t it be great to have an EASY button to push. Presto! Archive migration is done.
Unfortunately for IT professionals, there is no EASY button. As the saying goes, it’s complicated.
That was a key takeaway from a recent Fireside Chat webcast featuring Nick Cavalancia of Techvangelism, and Chris Clark, CEO of Trusted Data Solutions. They have both done email archive migrations and based on their experience it is never easy. Clark was emphatic that if a consultant tells you it is going to be easy, you better get that in writing.
Diverse and sometimes archaic or corrupted data formats are things that make archive migration complicated. But the good news is that while it is never going to be easy, careful preparation and planning can help you achieve a Zen-like balance between effortlessness and disastrous.
“One would think you get a migration tool, you point it at the source data then you point it at the destination environment and press start,” explained Nick Cavalancia of Techvangelism. “In concept, it seems like that’s all it really should be. But there’s so much more that needs to be addressed before you select a tool.”
Providers understand the importance of communicating with patients about gender-specific health risks and conditions. However, other less obvious differences in care expectations exist between the sexes. For example, a recent Intrado study found that male patients have a greater interest in receiving healthcare communications about bills and financial responsibilities than female patients.
A recent Intrado study found that female and male patients see greater value in different types of healthcare communications. To maximize engagement and participation in care, providers can customize automated communications beyond just addressing gender-specific health risks.
Ixia knows tests, how applications should perform, and security. We have deep knowledge concerning the challenges of maintaining a network solution that facilitates high-speed data moving through a network, along with the security and performance issues which inevitably arise. That is why we created the ATI Research Center, an elite group of top application and security researchers from around the globe. Their expertise spans software development, reverse engineering, vulnerability assessment and remediation, malware investigation, and intelligence gathering.
Managing a modern security architecture requires a wide range of in-depth skills and knowledge, which can be costly for IT teams to maintain. That’s where Ixia’s Application and Threat Intelligence (ATI) Research Centre comes in. We build decades of threat intelligence into Ixia products such as ThreatARMOR and BreakingPoint to provide your network with the best protection against vulnerabilities and cyberattacks.
There has never been a better time to build your custom application-specific integrated circuit (ASIC). Despite the talk of Moore’s Law slowing and the cost of new chips rising, there are many opportunities to turn your design or your multi-chip controller into a small ASIC to lower costs and protect your intellectual property (IP).
With physical network infrastructure moving to the cloud, it’s easy to think that networks are instantly faster, more reliable, limitless, and cheap. This fallacy is one of the biggest drivers of cloud deployment mistakes. Learn how to avoid the top network-related cloud deployment mistakes.
“With lack of visibility into how cloud resources are utilized, it’s easy to make costly mistakes.”
The rapid expansion of cloud-deployed applications is one of the most obvious trends in enterprise technology. The pace of this expansion is no surprise either— cloud technology is laden with benefits and promises. Most often we hear about benefits like “faster,” “lower cost,” “at the speed of business,” “operational efficiency,” “high performance,” “scale rapidly,” and “improved ROI.”
Cloud technology can be complex though, especially when it comes to networking. It’s full of new concepts like VPCs, cloud interconnects, and multiple availability zones and regions. Combined with the rapid pace of deployment and lack of visibility into how cloud resources are being utilized, it’s easy to make costly mistakes.
In this article, we discuss five network-related cloud deployment mistakes that you might not be aware of, but that can negate cloud benefits you’re hoping to achieve. The good news is: There’s always an opportunity to learn from mistakes.
Topics discussed in this article include:
The risks and costs associated with redundant cloud-based services.
The importance of avoiding “hair-pin” traffic routing scenarios when configuring cloud services.
How to minimize costs by minimizing unnecessary inter-region traffic.
Understanding the network behavior of cloud services and taking advantage of basic optimization, configuration, and compression opportunities.
Recommendations for reducing Internet content delivery costs.